{"entity":{"type":"insider","cik":"0001776938","url":"/insider/0001776938","json_url":"/insider/0001776938.json","name":"Lee Kevin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":71,"n_filings":29,"first":"2021-01-15","last":"2026-07-07","span_basis":"filed_date"},"name_variants":[{"name":"Lee Kevin","source":"filing","n_filings":29,"first_seen":"2021-01-15","last_seen":"2026-07-07"}],"transactions":[{"id":5758713,"accession":"0001776938-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001776938-26-000006","line_url":"/filing/0001776938-26-000006#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1737.0,"shares_display":"1,737","price_per_share":4.31,"price_display":"4.31","price_state":"stated","total_value":7486.47,"total_display":"7,486.47","total_whole":"7,486","shares_owned_after":603671.0,"shares_owned_after_display":"603,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-06","filed_date":"2026-07-07","scope":"insider"},{"id":5758712,"accession":"0001776938-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001776938-26-000006","line_url":"/filing/0001776938-26-000006#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5905.0,"shares_display":"5,905","price_per_share":4.27,"price_display":"4.27","price_state":"stated","total_value":25214.35,"total_display":"25,214.35","total_whole":"25,214","shares_owned_after":605408.0,"shares_owned_after_display":"605,408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-02","filed_date":"2026-07-07","scope":"insider"},{"id":5935426,"accession":"0001776938-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001776938-26-000004","line_url":"/filing/0001776938-26-000004#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1716.0,"shares_display":"1,716","price_per_share":5.05,"price_display":"5.05","price_state":"stated","total_value":8665.8,"total_display":"8,665.80","total_whole":"8,666","shares_owned_after":611313.0,"shares_owned_after_display":"611,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-06","filed_date":"2026-04-06","scope":"insider"},{"id":5935423,"accession":"0001776938-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001776938-26-000004","line_url":"/filing/0001776938-26-000004#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5967.0,"shares_display":"5,967","price_per_share":4.91,"price_display":"4.91","price_state":"stated","total_value":29297.97,"total_display":"29,297.97","total_whole":"29,298","shares_owned_after":613029.0,"shares_owned_after_display":"613,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-02","filed_date":"2026-04-06","scope":"insider"},{"id":6078948,"accession":"0001776938-26-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001776938-26-000002","line_url":"/filing/0001776938-26-000002#line-3","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10989.0,"shares_display":"10,989","price_per_share":6.46,"price_display":"6.46","price_state":"stated","total_value":70988.94,"total_display":"70,988.94","total_whole":"70,989","shares_owned_after":618996.0,"shares_owned_after_display":"618,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-06","scope":"insider"},{"id":6078945,"accession":"0001776938-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001776938-26-000002","line_url":"/filing/0001776938-26-000002#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10325.0,"shares_display":"10,325","price_per_share":6.8,"price_display":"6.80","price_state":"stated","total_value":70210.0,"total_display":"70,210.00","total_whole":"70,210","shares_owned_after":629985.0,"shares_owned_after_display":"629,985","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-06","scope":"insider"},{"id":4843960,"accession":"0001776938-25-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001776938-25-000004","line_url":"/filing/0001776938-25-000004#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3231.0,"shares_display":"3,231","price_per_share":8.41,"price_display":"8.41","price_state":"stated","total_value":27172.71,"total_display":"27,172.71","total_whole":"27,173","shares_owned_after":475310.0,"shares_owned_after_display":"475,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-06","scope":"insider"},{"id":4843955,"accession":"0001776938-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001776938-25-000004","line_url":"/filing/0001776938-25-000004#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2263.0,"shares_display":"2,263","price_per_share":8.4,"price_display":"8.40","price_state":"stated","total_value":19009.2,"total_display":"19,009.20","total_whole":"19,009","shares_owned_after":478541.0,"shares_owned_after_display":"478,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-06","scope":"insider"},{"id":4770769,"accession":"0001415889-25-019428","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-019428","line_url":"/filing/0001415889-25-019428#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3193.0,"shares_display":"3,193","price_per_share":7.44,"price_display":"7.44","price_state":"stated","total_value":23755.92,"total_display":"23,755.92","total_whole":"23,756","shares_owned_after":480804.0,"shares_owned_after_display":"480,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-03","filed_date":"2025-07-07","scope":"insider"},{"id":4770767,"accession":"0001415889-25-019428","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-019428","line_url":"/filing/0001415889-25-019428#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2268.0,"shares_display":"2,268","price_per_share":7.09,"price_display":"7.09","price_state":"stated","total_value":16080.12,"total_display":"16,080.12","total_whole":"16,080","shares_owned_after":483997.0,"shares_owned_after_display":"483,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-02","filed_date":"2025-07-07","scope":"insider"},{"id":4358106,"accession":"0001415889-25-010243","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-010243","line_url":"/filing/0001415889-25-010243#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3432.0,"shares_display":"3,432","price_per_share":7.48,"price_display":"7.48","price_state":"stated","total_value":25671.36,"total_display":"25,671.36","total_whole":"25,671","shares_owned_after":486265.0,"shares_owned_after_display":"486,265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-03","filed_date":"2025-04-04","scope":"insider"},{"id":4358100,"accession":"0001415889-25-010243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-010243","line_url":"/filing/0001415889-25-010243#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2237.0,"shares_display":"2,237","price_per_share":8.02,"price_display":"8.02","price_state":"stated","total_value":17940.74,"total_display":"17,940.74","total_whole":"17,941","shares_owned_after":489697.0,"shares_owned_after_display":"489,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-02","filed_date":"2025-04-04","scope":"insider"},{"id":4074149,"accession":"0001415889-25-000921","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-000921","line_url":"/filing/0001415889-25-000921#line-3","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3092.0,"shares_display":"3,092","price_per_share":14.75,"price_display":"14.75","price_state":"stated","total_value":45607.0,"total_display":"45,607.00","total_whole":"45,607","shares_owned_after":491934.0,"shares_owned_after_display":"491,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-03","filed_date":"2025-01-06","scope":"insider"},{"id":4074148,"accession":"0001415889-25-000921","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-000921","line_url":"/filing/0001415889-25-000921#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9038.0,"shares_display":"9,038","price_per_share":14.09,"price_display":"14.09","price_state":"stated","total_value":127345.42,"total_display":"127,345.42","total_whole":"127,345","shares_owned_after":495026.0,"shares_owned_after_display":"495,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-06","scope":"insider"},{"id":3143646,"accession":"0001415889-24-024772","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-024772","line_url":"/filing/0001415889-24-024772#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3212.0,"shares_display":"3,212","price_per_share":22.26,"price_display":"22.26","price_state":"stated","total_value":71499.12,"total_display":"71,499.12","total_whole":"71,499","shares_owned_after":380864.0,"shares_owned_after_display":"380,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-03","filed_date":"2024-10-04","scope":"insider"},{"id":2530431,"accession":"0001415889-24-019384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-019384","line_url":"/filing/0001415889-24-019384#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS PLC","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3194.0,"shares_display":"3,194","price_per_share":19.64,"price_display":"19.64","price_state":"stated","total_value":62730.16,"total_display":"62,730.16","total_whole":"62,730","shares_owned_after":384076.0,"shares_owned_after_display":"384,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-03","filed_date":"2024-07-08","scope":"insider"},{"id":3053297,"accession":"0001415889-24-010418","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-010418","line_url":"/filing/0001415889-24-010418#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3158.0,"shares_display":"3,158","price_per_share":23.81,"price_display":"23.81","price_state":"stated","total_value":75191.98,"total_display":"75,191.98","total_whole":"75,192","shares_owned_after":387270.0,"shares_owned_after_display":"387,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-03","filed_date":"2024-04-05","scope":"insider"},{"id":2178318,"accession":"0001209191-24-000875","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-000875","line_url":"/filing/0001209191-24-000875#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8703.0,"shares_display":"8,703","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":152302.5,"total_display":"152,302.50","total_whole":"152,303","shares_owned_after":390428.0,"shares_owned_after_display":"390,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-04","scope":"insider"},{"id":7999647,"accession":"0001209191-23-052249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-052249","line_url":"/filing/0001209191-23-052249#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1470.0,"shares_display":"1,470","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":29400.0,"total_display":"29,400.00","total_whole":"29,400","shares_owned_after":322131.0,"shares_owned_after_display":"322,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-03","filed_date":"2023-10-05","scope":"insider"},{"id":8188965,"accession":"0001209191-23-041571","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-041571","line_url":"/filing/0001209191-23-041571#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1498.0,"shares_display":"1,498","price_per_share":25.1,"price_display":"25.10","price_state":"stated","total_value":37599.8,"total_display":"37,599.80","total_whole":"37,600","shares_owned_after":323601.0,"shares_owned_after_display":"323,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-06","scope":"insider"},{"id":8365526,"accession":"0001209191-23-023342","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023342","line_url":"/filing/0001209191-23-023342#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1486.0,"shares_display":"1,486","price_per_share":21.11,"price_display":"21.11","price_state":"stated","total_value":31369.46,"total_display":"31,369.46","total_whole":"31,369","shares_owned_after":325099.0,"shares_owned_after_display":"325,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":7895726,"accession":"0001209191-23-002178","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-002178","line_url":"/filing/0001209191-23-002178#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":29.06,"price_display":"29.06","price_state":"stated","total_value":174360.0,"total_display":"174,360.00","total_whole":"174,360","shares_owned_after":326585.0,"shares_owned_after_display":"326,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":4188109,"accession":"0001209191-21-060745","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-060745","line_url":"/filing/0001209191-21-060745#line-3","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49.0,"shares_display":"49","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":2940.0,"total_display":"2,940.00","total_whole":"2,940","shares_owned_after":225085.0,"shares_owned_after_display":"225,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-18","filed_date":"2021-10-18","scope":"insider"},{"id":4188106,"accession":"0001209191-21-060745","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-060745","line_url":"/filing/0001209191-21-060745#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":320.0,"shares_display":"320","price_per_share":60.05,"price_display":"60.05","price_state":"stated","total_value":19216.0,"total_display":"19,216.00","total_whole":"19,216","shares_owned_after":225134.0,"shares_owned_after_display":"225,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-15","filed_date":"2021-10-18","scope":"insider"},{"id":4188102,"accession":"0001209191-21-060745","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-060745","line_url":"/filing/0001209191-21-060745#line-1","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4631.0,"shares_display":"4,631","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":277860.0,"total_display":"277,860.00","total_whole":"277,860","shares_owned_after":225454.0,"shares_owned_after_display":"225,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-14","filed_date":"2021-10-18","scope":"insider"},{"id":5113177,"accession":"0001209191-21-060383","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-060383","line_url":"/filing/0001209191-21-060383","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":53.87764,"price_display":"53.88","price_state":"stated","total_value":269388.2,"total_display":"269,388.20","total_whole":"269,388","shares_owned_after":230683.0,"shares_owned_after_display":"230,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-11","filed_date":"2021-10-13","scope":"insider","n_lines":2},{"id":5478211,"accession":"0001209191-21-054787","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-054787","line_url":"/filing/0001209191-21-054787#line-5","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":235085.0,"shares_owned_after_display":"235,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-03","scope":"insider"},{"id":5478210,"accession":"0001209191-21-054787","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-054787","line_url":"/filing/0001209191-21-054787","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27085.0,"shares_display":"27,085","price_per_share":37.21237659220971,"price_display":"37.21","price_state":"stated","total_value":1007897.22,"total_display":"1,007,897.22","total_whole":"1,007,897","shares_owned_after":241881.0,"shares_owned_after_display":"241,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-03","scope":"insider","n_lines":3},{"id":4486103,"accession":"0001209191-21-054118","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-054118","line_url":"/filing/0001209191-21-054118","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11225.0,"shares_display":"11,225","price_per_share":36.32632071269488,"price_display":"36.33","price_state":"stated","total_value":407762.95,"total_display":"407,762.95","total_whole":"407,763","shares_owned_after":245552.0,"shares_owned_after_display":"245,552","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-31","filed_date":"2021-08-31","scope":"insider","n_lines":2},{"id":4486091,"accession":"0001209191-21-054118","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-054118","line_url":"/filing/0001209191-21-054118#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1808.0,"shares_display":"1,808","price_per_share":36.02,"price_display":"36.02","price_state":"stated","total_value":65124.16,"total_display":"65,124.16","total_whole":"65,124","shares_owned_after":245085.0,"shares_owned_after_display":"245,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-27","filed_date":"2021-08-31","scope":"insider"},{"id":5000314,"accession":"0001209191-21-048348","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-048348","line_url":"/filing/0001209191-21-048348#line-4","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":36.0,"price_display":"36.00","price_state":"stated","total_value":3600.0,"total_display":"3,600.00","total_whole":"3,600","shares_owned_after":245085.0,"shares_owned_after_display":"245,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-26","filed_date":"2021-07-27","scope":"insider"},{"id":5000303,"accession":"0001209191-21-048348","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-048348","line_url":"/filing/0001209191-21-048348#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4782.0,"shares_display":"4,782","price_per_share":36.02,"price_display":"36.02","price_state":"stated","total_value":172247.64,"total_display":"172,247.64","total_whole":"172,248","shares_owned_after":245085.0,"shares_owned_after_display":"245,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-23","filed_date":"2021-07-27","scope":"insider"},{"id":4571917,"accession":"0001209191-21-046996","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-046996","line_url":"/filing/0001209191-21-046996#line-4","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":609.0,"shares_display":"609","price_per_share":34.0,"price_display":"34.00","price_state":"stated","total_value":20706.0,"total_display":"20,706.00","total_whole":"20,706","shares_owned_after":245085.0,"shares_owned_after_display":"245,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-16","filed_date":"2021-07-16","scope":"insider"},{"id":4571902,"accession":"0001209191-21-046996","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-046996","line_url":"/filing/0001209191-21-046996#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21970.0,"shares_display":"21,970","price_per_share":34.28,"price_display":"34.28","price_state":"stated","total_value":753131.6,"total_display":"753,131.60","total_whole":"753,132","shares_owned_after":245085.0,"shares_owned_after_display":"245,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-15","filed_date":"2021-07-16","scope":"insider"},{"id":4894705,"accession":"0001209191-21-046698","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-21-046698","line_url":"/filing/0001209191-21-046698","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14465.0,"shares_display":"14,465","price_per_share":34.33988247493951,"price_display":"34.34","price_state":"stated","total_value":496726.4,"total_display":"496,726.40","total_whole":"496,726","shares_owned_after":245138.0,"shares_owned_after_display":"245,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-14","filed_date":"2021-07-14","scope":"insider","n_lines":4},{"id":4894684,"accession":"0001209191-21-046698","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-046698","line_url":"/filing/0001209191-21-046698","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38961.0,"shares_display":"38,961","price_per_share":32.973488873488876,"price_display":"32.97","price_state":"stated","total_value":1284680.1,"total_display":"1,284,680.10","total_whole":"1,284,680","shares_owned_after":268201.0,"shares_owned_after_display":"268,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-13","filed_date":"2021-07-14","scope":"insider","n_lines":3},{"id":4894671,"accession":"0001209191-21-046698","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-046698","line_url":"/filing/0001209191-21-046698#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1936.0,"shares_display":"1,936","price_per_share":32.04,"price_display":"32.04","price_state":"stated","total_value":62029.44,"total_display":"62,029.44","total_whole":"62,029","shares_owned_after":254734.0,"shares_owned_after_display":"254,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-12","filed_date":"2021-07-14","scope":"insider"},{"id":4620923,"accession":"0001209191-21-031355","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-031355","line_url":"/filing/0001209191-21-031355#line-4","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5604.0,"shares_display":"5,604","price_per_share":32.23,"price_display":"32.23","price_state":"stated","total_value":180616.92,"total_display":"180,616.92","total_whole":"180,617","shares_owned_after":254734.0,"shares_owned_after_display":"254,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-07","filed_date":"2021-05-10","scope":"insider"},{"id":4620914,"accession":"0001209191-21-031355","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-031355","line_url":"/filing/0001209191-21-031355#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1716.0,"shares_display":"1,716","price_per_share":32.14,"price_display":"32.14","price_state":"stated","total_value":55152.24,"total_display":"55,152.24","total_whole":"55,152","shares_owned_after":254734.0,"shares_owned_after_display":"254,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-06","filed_date":"2021-05-10","scope":"insider"},{"id":4569725,"accession":"0001209191-21-030350","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-030350","line_url":"/filing/0001209191-21-030350#line-4","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":897.0,"shares_display":"897","price_per_share":32.03,"price_display":"32.03","price_state":"stated","total_value":28730.91,"total_display":"28,730.91","total_whole":"28,731","shares_owned_after":254734.0,"shares_owned_after_display":"254,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-05-05","scope":"insider"},{"id":4569716,"accession":"0001209191-21-030350","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-030350","line_url":"/filing/0001209191-21-030350#line-2","is_derivative":false,"issuer_cik":"0001761612","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001761612","owner_cik":"0001776938","owner_name":"Lee Kevin","owner_display_name":"Lee Kevin","owner_url":"/insider/0001776938","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3391.0,"shares_display":"3,391","price_per_share":32.16,"price_display":"32.16","price_state":"stated","total_value":109054.56,"total_display":"109,054.56","total_whole":"109,055","shares_owned_after":254734.0,"shares_owned_after_display":"254,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-05","scope":"insider"}],"collapsed":true,"next_cursor":"2021-05-03|4569716","ledger_fault":false,"count":{"value":71,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":71,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":71},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001761612","name":"BICYCLE THERAPEUTICS PLC","url":"/issuer/0001761612","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","n_filings":29,"first_seen":"2021-01-15","last_seen":"2026-07-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001776938","retrieved_at":"2026-08-27T05:02:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}